Shaoxing Zejun Pharmaceuticals Co., Ltd

小間番号：3A-20

カテゴリー：原料

企業情報

Email： service@zejunpharma.com TEL： +86-153-9585-6318 住所： No.3 East Weiwu Road, Shangyu District, Shaoxing 312369, P.R. China, 312369 312369 URL： http://www.zejunpharma.com

ZejunPharma strives to be a world-leading provider for green catalytic technologies, including structurally unique phosphorus ligands, chiral vicinal diamines, polymeric chiral materials, as well as innovative chemical processes of various APIs and chiral building blocks, serving for pharmaceutical, agrochemical, fine chemical companies and academia worldwide. ZejunPharma insists creating chemistry for a sustainable future, and focuses on efficient, economical, and environment-friendly catalytic technologies, we are specialized in cross-coupling, asymmetric hydrogenation and asymmetric transfer hydrogenation technologies, we also provide process development for API and chiral blocks, making our positive contribution in green synthesis.

企業情報

住所	No.3 East Weiwu Road, Shangyu District, Shaoxing 312369, P.R. China, 312369 312369
TEL	+86-153-9585-6318
FAX	+86-575-8212-6188
URL	http://www.zejunpharma.com
Email	service@zejunpharma.com

出展製品・サービス	Naltrexone hydrochloride (1R,2R)-(+)-1,2-Diphenylethylenediamine (1S,2S)-(+)-N-(4-Toluenesulfonyl)-1,2-diphenylethylenediamine (R,R)-N,N'-BIS(TRIFLUOROMETHANESULFONYL)-1,2-DIPHENYLETHYLENEDIAMINE (1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine (1S,2S)-(-)-1,2-Diphenyl-1,2-ethanediamine 3-(tert-butyl)-4- (2,6-dimethoxyphenyl) -2,3-dihydrobenzo [d][1,3]oxaphosphole 4-(anthracen-9-yl)-3-(tertbutyl)-2,3-dihydrobenzo[d] [1,3]oxaphosphole [(S,S)-Teth-TsDpen RuCl] (S,S)-N-(p-Toluenesulfonyl)-1,2-diphenylethanediamine(chloro)(p-cymene)ruthenium(II) Chloro{[(1S,2S)-(+)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido}(mesitylene)ruthenium(II), min. 90% RuCl[(S,S)-Tsdpen](mesitylene) RuCl[(S,S)-FsDPEN](p-cymene) 2-((2R,3R)-3-(tert-butyl)-4-(3,5-dicyclopentyl-2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)propan-2-ol (S)-3-(tert-butyl)-4-(2,6-di methoxyphenyl)-2,3-dihyd robenzo[d][1,3]oxaphosph ole (R)-3-(tert-butyl)-4-(2,6-di methoxyphenyl)-2,3-dihyd robenzo[d][1,3]oxaphosph ole (S)-4-(anthracen-9-yl)-3-(te rt-butyl)-2,3-dihydrobenzo [d][1,3]oxaphosphole (1S,2S)-(+)-N-(4-Toluenesulfonyl)-1,2-diphenylethylenediamine (R,R)-N,N'-BIS(TRIFLUOROMETHANESULFONYL)-1,2-DIPHENYLETHYLENEDIAMINE 1,2-Ethanediamine, 1,2-bis(4-methylphenyl)-, hydrochloride (1:2), (1S,2S)- Dichloro{(R)-(+)-2,2'-bis[di(3,5-xylyl)phosphino]-1,1'-binaphthyl}[(2R)-(-)-1,1-bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine]ruthenium(II)

出展製品・サービス

Naltrexone hydrochloride
(1R,2R)-(+)-1,2-Diphenylethylenediamine
(1S,2S)-(+)-N-(4-Toluenesulfonyl)-1,2-diphenylethylenediamine
(R,R)-N,N'-BIS(TRIFLUOROMETHANESULFONYL)-1,2-DIPHENYLETHYLENEDIAMINE
(1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine
(1S,2S)-(-)-1,2-Diphenyl-1,2-ethanediamine
3-(tert-butyl)-4- (2,6-dimethoxyphenyl) -2,3-dihydrobenzo [d][1,3]oxaphosphole
4-(anthracen-9-yl)-3-(tertbutyl)-2,3-dihydrobenzo[d] [1,3]oxaphosphole
[(S,S)-Teth-TsDpen RuCl]
(S,S)-N-(p-Toluenesulfonyl)-1,2-diphenylethanediamine(chloro)(p-cymene)ruthenium(II)
Chloro{[(1S,2S)-(+)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido}(mesitylene)ruthenium(II), min. 90% RuCl[(S,S)-Tsdpen](mesitylene)
RuCl[(S,S)-FsDPEN](p-cymene)
2-((2R,3R)-3-(tert-butyl)-4-(3,5-dicyclopentyl-2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)propan-2-ol
(S)-3-(tert-butyl)-4-(2,6-di methoxyphenyl)-2,3-dihyd robenzo[d][1,3]oxaphosph ole
(R)-3-(tert-butyl)-4-(2,6-di methoxyphenyl)-2,3-dihyd robenzo[d][1,3]oxaphosph ole
(S)-4-(anthracen-9-yl)-3-(te rt-butyl)-2,3-dihydrobenzo [d][1,3]oxaphosphole
(1S,2S)-(+)-N-(4-Toluenesulfonyl)-1,2-diphenylethylenediamine
(R,R)-N,N'-BIS(TRIFLUOROMETHANESULFONYL)-1,2-DIPHENYLETHYLENEDIAMINE
1,2-Ethanediamine, 1,2-bis(4-methylphenyl)-, hydrochloride (1:2), (1S,2S)-
Dichloro{(R)-(+)-2,2'-bis[di(3,5-xylyl)phosphino]-1,1'-binaphthyl}[(2R)-(-)-1,1-bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine]ruthenium(II)

出展製品・サービス

Naltrexone hydrochloride(1R,2R)-(+)-1,2-Diphenylethylenediamine(1S,2S)-(+)-N-(4-Toluenesulfonyl)-1,2-diphenylethylenediamine(R,R)-N,N'-BIS(TRIFLUOROMETHANESULFONYL)-1,2-DIPHENYLETHYLENEDIAMINE(1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine(1S,2S)-(-)-1,2-Diphenyl-1,2-ethanediamine3-(tert-butyl)-4- (2,6-dimethoxyphenyl) -2,3-dihydrobenzo [d][1,3]oxaphosphole4-(anthracen-9-yl)-3-(tertbutyl)-2,3-dihydrobenzo[d] [1,3]oxaphosphole[(S,S)-Teth-TsDpen RuCl](S,S)-N-(p-Toluenesulfonyl)-1,2-diphenylethanediamine(chloro)(p-cymene)ruthenium(II)Chloro{[(1S,2S)-(+)-2-amino-1,2-diphenylethyl](4-toluenesulfonyl)amido}(mesitylene)ruthenium(II), min. 90% RuCl[(S,S)-Tsdpen](mesitylene)RuCl[(S,S)-FsDPEN](p-cymene)2-((2R,3R)-3-(tert-butyl)-4-(3,5-dicyclopentyl-2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)propan-2-ol(S)-3-(tert-butyl)-4-(2,6-di methoxyphenyl)-2,3-dihyd robenzo[d][1,3]oxaphosph ole(R)-3-(tert-butyl)-4-(2,6-di methoxyphenyl)-2,3-dihyd robenzo[d][1,3]oxaphosph ole(S)-4-(anthracen-9-yl)-3-(te rt-butyl)-2,3-dihydrobenzo [d][1,3]oxaphosphole(1S,2S)-(+)-N-(4-Toluenesulfonyl)-1,2-diphenylethylenediamine(R,R)-N,N'-BIS(TRIFLUOROMETHANESULFONYL)-1,2-DIPHENYLETHYLENEDIAMINE1,2-Ethanediamine, 1,2-bis(4-methylphenyl)-, hydrochloride (1:2), (1S,2S)-Dichloro{(R)-(+)-2,2'-bis[di(3,5-xylyl)phosphino]-1,1'-binaphthyl}[(2R)-(-)-1,1-bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine]ruthenium(II)